Is It Time to Revisit the Role of Allogeneic Transplantation in Lymphoma

Purpose of Review A multitude of new drug and cell therapy approvals for lymphoma has prompted questions about the role of allogeneic blood or marrow transplantation (allo-BMT). We sought to review the latest evidence examining the role of allo-BMT for lymphoma in this evolving landscape.